Skip to main content

In autologous stem cell transplantation, the procedure uses the patient’s own stem cells for the transplant. The stem cells are collected from the patient in advance and are frozen. After the patient undergoes high doses of chemotherapy, either with or without radiation therapy, the stem cells are then returned to the body. This type of transplant is often used to treat blood cancers such as Hodgkin lymphoma, non-Hodgkin lymphoma and myeloma.

transplant image
In an autologous stem cell transplantation, the procedure uses the patient’s own stem cells for the transplant. This illustration explains all of the steps in this process.

An autologous stem cell transplant's goal is to restore the body's ability to make normal blood cells after high-dose chemotherapy or radiation. 

Such intensive treatments usually destroy cancer cells better than standard treatments, but these high-dose treatments are toxic and also destroy the blood-producing stem cells in the bone marrow. That is why the stem cells are removed before the treatment, so they can be treated outside of the body and reinfused after the treatment to make new blood cells in the bone marrow. This is called “engraftment.”

Engraftment occurs more quickly in an autologous transplantation than in an allogeneic transplantation because the frozen cells are the patient’s own stem cells, so graft failure (when the transplanted cells do not successfully grow and divide in the bone marrow) is rare, and graft-versus-host disease (GVHD) is never a problem.

Unlike allogeneic stem cell transplant, this procedure:

  • Doesn't offer the benefits of graft-versus-tumor (GVT) effect, when healthy donor cells attack cancer cells. As a result, there is a higher risk of relapse of the disease.
  • Doesn't carry the risk of GVHD

Tandem transplant

Most people have a single autologous transplant. Others may have a transplant called a “tandem transplant.” A tandem transplant involves a planned second autologous stem cell transplant after the first autologous transplant. All the stem cells are collected from the patient before the first-high dose chemotherapy treatment. 

After the first transplant, half of these stem cells are infused into the patient’s body. Usually, several weeks or months pass before the second course of high-dose chemotherapy. After the second course, the other half of the healthy stem cells that were originally removed are infused. This method is under study in clinical trials for the treatment of several types of cancer, including myeloma. 

Get free, one-on-one support

Call, email, or chat with a member of our highly trained support team.

Alec and Aden
Blood cancer survivors

Featured Image
Blood Cancer United Dare to Dream Project – Transforming treatment and care for kids

Kids deserve better.

Help transform treatment and care for kids and support all of the life-saving work that Blood Cancer United does.

Learn more

Blood Cancer United resources

Find free, specialized guidance and information for every type of blood cancer, request financial support, find emotional support, and connect with other members of the blood cancer community.

We are Blood Cancer United.

Everyone affected by blood cancer—patients, survivors, caregivers, researchers, advocates, fundraisers, everyone—has a story. Share yours.
Headshot of Michele a Leukemia Survivor smiling, wearing a white sweater.

Michele

Leukemia Survivor

A young person with short dark hair wearing a striped hoodie under a denim vest.

Kamal

Leukemia Survivor

Two people pose together at a nighttime Light The Night event, holding white, gold, and red lanterns.

Lisa

Lymphoma survivor

Lynette wearing a black “GO TEAM” hoodie stands in front of a Team in Training marathon display.

Lynette

Volunteer

Deanna and her husband pose together at Light The Night event, each holding illuminated paper lanterns. Deanne holds a white survivor lantern and her husband holds a red supporter lantern. Red and white lanterns glow in the background, with other attendees, colorful decorations, and an event tent visible in the background.

Deanna

ALL Survivor

Headshot of Todd wearing suit and tie, a cancer survivor

Todd

Volunteer

Smiling person with short hair and glasses photographed against a light background, expressing warmth, resilience, and hope while representing the blood cancer community.

Danyele

Hodgkin lymphoma (HL)

Bruce and his wife pose with their young children inside a large white blood-drop display covered in handwritten messages, with Blood Cancer United branding below.

Bruce

Hodgkin lymphoma (HL)

A person sits in a treatment chair wearing a black shirt that reads “DONE” with a purple heart ribbon, holding a small pillow with a photo of her dog on it while connected to medical equipment.

Jessica

Hodgkin lymphoma (HL)

Runner wearing a race bib runs along a city street during a road race.

Luke

leukemia

Young adult blood cancer survivor, Olivia, with her hands in the air celebrating

Olivia

Stage IVB Hodgkin lymphoma (HL)

Audience members gather in a small performance venue as a speaker shares a personal story on stage under purple lighting. The event highlights the power of storytelling, blood cancer awareness, survivorship, and community connection for people affected by blood cancer. People seated in an intimate theater setting watch a performer speak on stage beneath purple and blue lights. The image represents blood cancer storytelling, advocacy, and the sharing of lived experiences that help others feel seen and supported. A storyteller performs before a live audience in a cozy venue illuminated with purple stage lighting. The event showcases personal stories about blood cancer, resilience, and the healing impact of community and shared experiences.

Adam

leukemia

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.